Elanco CEO granted 127.8 deferred stock units

Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health Inc reported that President, CEO and Director Jeffrey N. Simmons received a grant of 127.7997 Deferred Stock Units on 2026-08-07 at a reference value of $22.12 per unit. Each deferred stock unit represents the right to receive one share of common stock or the cash equivalent and will settle in cash or shares following termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan. Following this award, Simmons holds 25,012.1875 Deferred Stock Units directly.

Insider Trade Summary

Grant/Award: 127.7997 shares

Grant/Award 1 txn

Insider Simmons Jeffrey N

Role PRESIDENT, CEO AND DIRECTOR

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units F1, F2	127.7997	$22.12	$3K

Holdings After Transaction: Deferred Stock Units — 25,012.1875 contracts (Direct)

Footnotes (2)

1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Key Figures

Deferred Stock Units granted: 127.7997 units Reference value per unit: $22.12 per unit Deferred Stock Units after grant: 25,012.1875 units +1 more

4 metrics

Deferred Stock Units granted 127.7997 units Grant to Jeffrey N. Simmons on 2026-08-07

Reference value per unit $22.12 per unit Deferred Stock Units award to Jeffrey N. Simmons

Deferred Stock Units after grant 25,012.1875 units Total Deferred Stock Units held directly by Jeffrey N. Simmons

Underlying common shares per unit 1 share per unit Each Deferred Stock Unit represents one share or cash equivalent

Key Terms

Deferred Stock Units, cash equivalent, Executive Deferral and Stock Match Plan

3 terms

Deferred Stock Units financial

"Each deferred stock unit represents the right to receive one share of Company common stock"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

cash equivalent financial

"the right to receive one share of Company common stock or the cash equivalent"

Executive Deferral and Stock Match Plan financial

"in accordance with Executive Deferral and Stock Match Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Elanco (ELAN) report for Jeffrey N. Simmons?

Elanco reported that Jeffrey N. Simmons received a grant of 127.7997 Deferred Stock Units on 2026-08-07. These units are linked to Elanco common stock and are part of his compensation package.

How many Deferred Stock Units does Jeffrey N. Simmons hold after this ELAN Form 4?

After the reported grant, Jeffrey N. Simmons holds 25,012.1875 Deferred Stock Units directly. These units track Elanco common stock value and are scheduled to settle in cash or shares in the future.

What does each Deferred Stock Unit represent for Elanco (ELAN)?

Each Elanco Deferred Stock Unit represents the right to receive one share of common stock or the cash equivalent. The actual settlement form is determined under the company’s Executive Deferral and Stock Match Plan.

When will Jeffrey N. Simmons’s Deferred Stock Units in ELAN settle?

The Deferred Stock Units will settle in cash or shares after termination of employment or during a specified future year. Settlement timing follows the terms of Elanco’s Executive Deferral and Stock Match Plan.

What was the reference value per Deferred Stock Unit in the latest ELAN grant?

The reported grant to Jeffrey N. Simmons used a reference value of $22.12 per Deferred Stock Unit. This value is tied to the company’s common stock for this compensation-related award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/10/2026 - 04:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Simmons Jeffrey N

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT, CEO AND DIRECTOR

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	08/07/2026		A		127.7997		(2)	(2)	Common Stock	127.7997	$22.12	25,012.1875	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)